Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
Reference: 20230332
Release date: 13 September 2023

Promoter – Financial Intermediary

BIOHOPE SCIENTIFIC SOLUTIONS FOR HUMAN HEALTH SL

Location

Description

Company dedicated to the development of precision medicine in-vitro diagnostic tools for chronic inflammatory conditions

Objectives

The loan will finance the research and development (R&D) investments to further advance the promoter's product pipeline and bring the products to the medical market.

Sector(s)

Proposed EIB finance (Approximate amount)

EUR 15 million

Total cost (Approximate amount)

EUR 34 million

Environmental aspects

The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

Procurement

The promoter is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is not covered by EU Directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank's services will verify details during the project due diligence.

Status

Signed - 20/12/2023

Milestone
Under appraisal
Approved
Signed
10 October 2023
20 December 2023

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Related tags

Spain Industry